|
Volumn 4, Issue 5, 2010, Pages 731-735
|
Biomarkers in Parkinsons disease: A venture capitalists perspective
|
Author keywords
biomarker; clinical trial outcome; early stage investingn venture capital
|
Indexed keywords
BIOLOGICAL MARKER;
CAPITAL;
CLINICAL RESEARCH;
CONFIDENTIALITY;
COST EFFECTIVENESS ANALYSIS;
DRUG INDUSTRY;
DRUG RESPONSE;
ECONOMIC ASPECT;
FUNDING;
INVESTMENT;
PARKINSON DISEASE;
REIMBURSEMENT;
REVIEW;
ARTICLE;
ECONOMICS;
HUMAN;
INFORMATION PROCESSING;
BIOLOGICAL MARKERS;
DATA COLLECTION;
DRUG INDUSTRY;
HUMANS;
PARKINSON DISEASE;
|
EID: 77958045185
PISSN: 17520363
EISSN: None
Source Type: Journal
DOI: 10.2217/bmm.10.91 Document Type: Review |
Times cited : (3)
|
References (9)
|